Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Study to evaluate the efficacy and safety of the combination of Atezolizumab and Bevacizumab as neoadjuvant plus adjuvant treatment in Hepatocellular Carcinoma.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Potwierdzony rozpoznaniem nowotworu wątroby (HCC)
- •Guz można całkowicie usunąć operacyjnie w zamiarze leczniczym
- •Guz ma cechy wysokiego ryzyka nawrotu (jest wieloogniskowy, duży ponad 5 cm, wysoki marker AFP, słaba różniczkowanie lub obecność przerzutów drobnych naczyń)
- •Zdiagnozowana mierzalna zmiana nowotworu
- •Ogólny stan zdrowia dobry (skala ECOG 0)
- •Dobra funkcja wątroby (klasa Child-Pugh A)
- •Brak poważnego zwiększenia ciśnienia w żyłach wątroby
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 8, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (12)
Hospital Universitari Germans Trias i Pujol
Badalona, Spain
Hospital Universitari de Bellvitge
Barcelona, Spain
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Hospital Universitario Marqués de Valdecilla
Santander, Spain
Hospital Universitario Reina Sofía
Córdoba, Spain
Hospital Universitari Josep Trueta
Girona, Spain
Hospital General Universitario Gregorio Marañón
Madrid, Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain
Hospital Universitario Virgen de la Victoria
Puerto de la Torre, Spain
Hospital Universitario y Politécnico La Fe
Valencia, Spain
Hospital Universitario de Cruces
Barakaldo, Spain
Trial contact
Ezequiel Matias Mauro, MD, PhD
Eva Bonfill Vernet
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.